Treatment and Survival Differences between Patients with Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma of the Breast
The results of this study add to the currently conflicting literature of survival of ILC and demonstrate the importance of evaluating novel therapeutic approaches and extended therapy for patients with ILC.
Authors
- Samilia Obeng‐Gyasi (ORCID: https://orcid.org/0000-0002-5330-7247)
- Xiaonan Xue (ORCID: https://orcid.org/0000-0003-2872-8119)
- Jesus D. Anampa (ORCID: https://orcid.org/0000-0002-1898-180X)
- Shuwen Lin (ORCID: https://orcid.org/0009-0003-9197-7887)
Institutions
- Albert Einstein College of Medicine (US)
- Montefiore Medical Center (US)
- Ohio State University Hospital (US)
- The Ohio State University (US)
Publication Details
- Journal
- Cancer Epidemiology Biomarkers & Prevention
- Published
- 2024-10-24
- DOI
- https://doi.org/10.1158/1055-9965.epi-24-1250
- Citations
- 3
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.86
Funders
- National Institutes of Health
- National Center for Advancing Translational Sciences